ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00371553
Recruitment Status : Completed
First Posted : September 4, 2006
Last Update Posted : July 8, 2009
Sponsor:
Collaborators:
Canadian Urologic Oncology Group
NCIC Testis Group
German Testicular Cancer Study Group
Information provided by:
British Columbia Cancer Agency

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2009
  Actual Study Completion Date : June 2009